300 related articles for article (PubMed ID: 2148146)
1. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
[TBL] [Abstract][Full Text] [Related]
4. Long-term profile of a new progestin.
Lippman J
Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
[TBL] [Abstract][Full Text] [Related]
5. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
6. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
Spellacy WN; Ellingson AB; Tsibris JC
J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
[TBL] [Abstract][Full Text] [Related]
7. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
8. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
Spellacy WN; Birk SA; Buggie J; Buhi WC
J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
[TBL] [Abstract][Full Text] [Related]
9. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya.
Maina FW; Sekadde-Kigondu CB; Ojwang PJ; Mati JK
East Afr Med J; 1987 Jul; 64(7):442-7. PubMed ID: 3691360
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
12. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.
de Abood M; de Castillo Z; Guerrero F; Espino M; Austin KL
Contraception; 1997 Nov; 56(5):313-6. PubMed ID: 9437560
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Albus C; Männchen E
Zentralbl Gynakol; 1987; 109(8):521-6. PubMed ID: 3111130
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral contraceptives on carbohydrate metabolism.
Wynn V; Godsland I
J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Petersen KR; Skouby SO; Dreisler A; Kühl C
Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
[TBL] [Abstract][Full Text] [Related]
17. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
[TBL] [Abstract][Full Text] [Related]
18. Clinical and endocrine effects of long-term hormonal contraception.
Balogh A
Acta Med Hung; 1986; 43(2):97-102. PubMed ID: 3588164
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
[TBL] [Abstract][Full Text] [Related]
20. Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives.
Vermeulen A; Thiery M
Diabetologia; 1974 Aug; 10(4):253-9. PubMed ID: 4213146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]